gastric cancer
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. having been diagnosed with gastric cancer by specialists according to histopathologic examination; 2. having completed the lobectomy; 3. having finished the adjuvant chemotherapy or radiotherapy after the surgery; 4. joining in the study of their own accord.
Exclusion criteria
Exclusion criteria: 1. patients with uncertain diagnosis; 2. medically inoperable patients; 3. patients during the process of chemotherapy or radiotherapy; 4. patients with advanced disease, such as malignant pleural effusion and involvement or distant metastasis; 5. diabetic patients and patients with dermatosis or other diseases affecting the kin to heal; 6. disagreeing to join in the trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| White blood cells;lymphocyte;neutrophil;Platelet;CD19+;CD28+;CD8+/CD28+;CD8+/CD28-;CD3+;CD3+/HLA-DR+;CD3+/HR-DR-;CD-/CD16+56+;CD4+CD25+;CD4+/CD29+;CD4+/CD45RA+;CD4+/CD45RO+;Differential expression analysis of genes;GO and KEGG function notes;rng-seq analysis; | — |
Secondary
| Measure | Time frame |
|---|---|
| European Organization for Research and Treatment of Cancer Quality of Life Questionnaire; | — |
Countries
China
Contacts
Peoples Liberation Army General Hospital